GS

Gaddipati Sankar Basava

Director Director DIN 01908672
DIN 01908672 First appointment Jan 2005 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2005
Shareholding value β€’β€’β€’β€’ Premium profile

About Gaddipati Sankar Basava

Data last updated:

Gaddipati Sankar Basava was a Director at Pellets Pharma Limited (2005–2024) and Director at Pellets Pharma (India) Private Limited (from 2010). The companies operate in Pharma.

DIN 01908672
Primary Designation Director
Industry Pharma
First Appointment 15 Jan 2005
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pellets Pharma Limited U24239TG2004PLC042853
Director15 Jan 20052004₹72.09 Cr (FY 2024)Active
Director24 May 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pellets Pharma (India) Private Limited
Pellets Pharma Limited
Premium access

Shareholding and investment profile for Gaddipati Sankar Basava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gaddipati Sankar Basava

Gaddipati Sankar Basava was first appointed on 15 Jan 2005 as Director at Pellets Pharma Limited. The most recent appointment on record is 24 May 2010 at Pellets Pharma (India) Private Limited.

Gaddipati Sankar Basava held 2 earlier board appointments: Pellets Pharma Limited (Director, 15 Jan 2005 to 30 Sep 2024); Pellets Pharma (India) Private Limited (Director, from 24 May 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available